EIZO Corporation Revises Earnings Forecast — Net Profit Up 128%
EIZO Corporation (TSE:6737) raised its full-year earnings guidance for the fiscal year ending March 2026, driven by stronger healthcare market demand and a one-time investment gain.
| Item | Before | After | Change | Change % |
|---|---|---|---|---|
| Revenue | JPY 79.0bn | JPY 81.3bn | JPY 2.3bn | 2.9% |
| Operating Profit | JPY 1.4bn | JPY 2.3bn | JPY 0.9bn | 64.3% |
| Ordinary Income | JPY 2.9bn | JPY 3.7bn | JPY 0.8bn | 27.6% |
| Net Profit | JPY 3.2bn | JPY 7.3bn | JPY 4.1bn | 128.1% |
| EPS | JPY 78.93/share | JPY 180.06/share | JPY 101.13/share | 128.1% |
The display maker cited recovering sales in Europe, North America, and China within its healthcare segment, offsetting earlier softness in Japan due to hospital operating pressures. The company expects to capture year-end demand across all regions. Revenue upside flows through to operating and ordinary income (keijo rieki), a Japan-specific profit metric that includes non-operating items. The net profit surge reflects an anticipated JPY 6.6bn gain from investment securities sales in the fourth quarter, partially offset by JPY 0.95bn in restructuring charges and asset impairments related to European operations, plus JPY 0.4bn in inventory write-downs for legacy B&P market products.
The revision signals cautious optimism in healthcare demand recovery while exposing inventory management challenges and ongoing European restructuring. The company maintained its dividend unchanged, suggesting management prioritizes balance-sheet flexibility amid ongoing operational adjustments. International investors should note that ordinary income differs materially from operating profit due to financial income and expenses—a distinction unique to Japanese reporting standards.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Always verify against the original filing.